No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
orangejus : I think recent market dip told us that’s not true… Pfizer dropped by almost 20%
Deep Sea OP orangejus : Today tech stocks drop and PFE is going the opposite way. It could be due to delay in pharma tariffs and management earnings guidance for FY25 remains the same.
orangejus : Pharma tariffs being unresolved should make you very cautious about pharma stocks atm. I’m long PFE, but the recent sharp pullback of what I considered a relatively safe stock has made me reconsider my thesis.
Deep Sea OP : Dividend yield is 6.9% which is higher than bank FD. It shows that the stock is cheap and undervalued.
Deep Sea OP orangejus : Below is the tariffs actively addressed by PFE management:
"In terms of the supply chain, Pfizer is proactively addressing potential pharmaceutical tariff risks in the USA by considering shifting some overseas production back domestically. With 10 existing manufacturing bases and 2 distribution centers, Pfizer has the supply chain resilience to adjust quickly, which is a positive signal for maintaining long-term operational stability."